(Q36958826)

17 August 2017

Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality (English)

1 reference

17 August 2017

1 reference

1 reference

5

Melissa Soohoo

0 references

Elani Streja

1

object named as

Elani Streja

0 references

Kamyar Kalantar-Zadeh

8

object named as

Kamyar Kalantar-Zadeh

0 references

Connie M Rhee

6

object named as

Connie M Rhee

1 reference

17 August 2017

7

Onyebuchi A Arah

1 reference

17 August 2017

Jongha Park

2

1 reference

PMCID

4889858

17 August 2017

Ting-Yan Chan

3

1 reference

PMCID

4889858

17 August 2017

Janet Lee

4

1 reference

17 August 2017

19 May 2016

1 reference

International Journal of Nephrology

17 August 2017

1 reference

17 August 2017

2016

1 reference

17 August 2017

6087134

1 reference

Creative Commons Attribution 4.0 International

17 August 2017

start time

1 January 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

High-dose erythropoietin for tissue protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Relationship between epoetin alfa dose and mortality: findings from a marginal structural model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Constructing inverse probability weights for marginal structural models

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

History-adjusted marginal structural models for estimating time-varying effect modification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Estimating causal effects from epidemiological data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Marginal structural models and causal inference in epidemiology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Erythropoietin receptor mRNA expression in human endothelial cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Inactivation of erythropoietin leads to defects in cardiac morphogenesis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Thrombocytosis in EPO-treated dialysis patients may be mediated by EPO rather than iron deficiency.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4889858

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans

4 September 2018

1 reference

12 December 2020

Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients

1 reference

12 December 2020

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

12 December 2020

Identifiers

DOI

10.1155/2016/6087134

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

PMCID

4889858